Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
160.64
+1.00 (+0.63%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Courts, Congress Likely to Stand in Way of J&J’s Third Texas Two-Step Plan
Today 9:38 EDT
From
Beasley Allen Law Firm
Via
Business Wire
FINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan
Today 9:05 EDT
From
Ad Hoc Group of Counsel
Via
Business Wire
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
July 23, 2024
From
Johnson & Johnson
Via
Business Wire
Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
July 22, 2024
Intuitive Surgical is an AI stock that you can buy and hold forever. Its business is health care; it makes profits, and health care is growing
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Lawyers for Ovarian Cancer Victims Urge NO Vote on J&J’s Latest Bankruptcy Plan
July 22, 2024
From
Beasley Allen Law Firm
Via
Business Wire
MarketBeat Week in Review – 7/15 - 7/19
July 20, 2024
Stocks took a breather to close the week, but corporate earnings and the next reading on the PCE index will help determine what direction the market moves next
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
This Medical Giant's Stock Rebounds: A 15% Upside Is the Minimum
July 17, 2024
Johnson & Johnson reported a solid quarter for Q2 but issued mixed guidance. The critical detail is that sequential growth continues, and YOY growth is on tap.
Via
MarketBeat
Exposures
COVID-19
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson reports Q2 2024 results
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
July 15, 2024
From
NKGen Biotech
Via
GlobeNewswire
MarketBeat Week in Review – 7/8 - 7/12
July 13, 2024
Stocks took investors on quite a ride this week, with the S&P 500 hitting a new record high, then falling back on Thursday before rallying to end the week
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
July 11, 2024
From
Johnson & Johnson
Via
Business Wire
Nasdaq vs. Dow Jones: A Detailed Breakdown of Stock Indexes
July 05, 2024
Nasdaq focuses on tech and growth stocks, offering high returns with higher volatility. Dow covers diverse sectors, providing steadier, lower-risk performance.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
AbbVie Stock: A Perfect Dip for Investors to Buy
July 03, 2024
ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors
Via
MarketBeat
Topics
ETFs
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
July 02, 2024
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.
Via
MarketBeat
Topics
ETFs
Exposures
COVID-19
Lawyers for Johnson & Johnson’s Ovarian Cancer Victims React to SCOTUS Decision in Purdue
June 27, 2024
From
Beasley Allen
Via
Business Wire
The Top 3 Sectors Poised For Growth This Summer
June 24, 2024
Communications, technology, and healthcare are the three hottest sectors for growth, but not all stocks will rise with the tides.
Via
MarketBeat
Topics
ETFs
Johnson & Johnson Completes Acquisition of Proteologix, Inc.
June 21, 2024
From
Johnson & Johnson
Via
Business Wire
More than 60 Law Firms Oppose J&J Prepack Bankruptcy Scheme
June 20, 2024
From
Beasley Allen
Via
Business Wire
Beasley Allen and Levin Papantonio: Leading Law Firms Seek Protection for Future Victims of Johnson & Johnson Talc Products
June 17, 2024
From
Beasley Allen
Via
Business Wire
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
June 17, 2024
EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END
Via
FinancialNewsMedia
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
June 17, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Talc Plaintiffs File Motion for Temporary Restraining Order to Limit Johnson & Johnson’s Use of Bankruptcy Strategy
June 12, 2024
From
Beasley Allen Law Firm
Via
Business Wire
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
June 04, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Completes Acquisition of Shockwave Medical
May 31, 2024
From
Johnson & Johnson
Via
Business Wire
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
May 28, 2024
From
Numab Therapeutics AG
Via
GlobeNewswire
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
May 28, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
May 16, 2024
From
Johnson & Johnson
Via
Business Wire
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
May 09, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END
Via
FinancialNewsMedia
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 08, 2024
From
Johnson & Johnson
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.